참고문헌
- Diekema DJ, Pfaller MA, Jones RN, et al. Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997. Clin Infect Dis 1999;29:595-607. https://doi.org/10.1086/598640
- Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52:e103-e120. https://doi.org/10.1093/cid/ciq257
- Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010;50:133-164. https://doi.org/10.1086/649554
- Cheong HJ, Yoo CW, Sohn JW, Kim WJ, Kim MJ, Park SC. Bacteremia due to quinolone-resistant Escherichia coli in a teaching hospital in South Korea. Clin Infect Dis 2001;33:48-53. https://doi.org/10.1086/320873
- Ena J, Lopez-Perezagua MM, Martinez-Peinado C, Cia-Barrio MA, Ruiz-Lopez I. Emergence of ciprof loxacin resistance in Escherichia coli isolates after widespread use of fluoroquinolones. Diagn Microbiol Infect Dis 1998;30:103-107. https://doi.org/10.1016/S0732-8893(97)00216-2
- Lee H, Kim CK, Lee J, et al. Antimicrobial resistance of clinically important bacteria isolated from 12 hospitals in Korea in 2005 and 2006. Korean J Clin Microbiol 2007;10:59-69.
- Hawser SP, Bouchillon SK, Hoban DJ, Badal RE, Canton R, Baquero F. Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in communityand hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother 2010;54:3043-3046. https://doi.org/10.1128/AAC.00265-10
- Pitout JD, Gregson DB, Church DL, Laupland KB. Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary. Emerg Infect Dis 2007;13:443-448. https://doi.org/10.3201/eid1303.060447
- Rodriguez-Bano J, Picon E, Gijon P, et al. Communityonset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis 2010;50:40-48. https://doi.org/10.1086/649537
- Kang CI, Song JH, Chung DR, et al. Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli. Int J Antimicrob Agents 2010;36:284-287. https://doi.org/10.1016/j.ijantimicag.2010.05.009
- Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383. https://doi.org/10.1016/0021-9681(87)90171-8
- Paterson DL, Ko WC, Von Gottberg A, et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections. Ann Intern Med 2004;140:26-32. https://doi.org/10.7326/0003-4819-140-1-200401060-00008
- Courpon-Claudinon A, Lefort A, Panhard X, et al. Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features. Clin Microbiol Infect 2011;17:557-565. https://doi.org/10.1111/j.1469-0691.2010.03298.x
- Livermore DM, Hope R, Brick G, Lillie M, Reynolds R; BSAC Working Parties on Resistance Surveillance. Nonsusceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06. J Antimicrob Chemother 2008;62 Suppl 2:ii41-ii54. https://doi.org/10.1093/jac/dkn169
- Wang P, Hu F, Xiong Z, et al. Susceptibility of extended-spectrum-beta-lactamase-producing Enterobacteriaceae according to the new CLSI breakpoints. J Clin Microbiol 2011;49:3127-3131. https://doi.org/10.1128/JCM.00222-11
- Song W, Lee H, Lee K, et al. CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum beta-lactamase in clinical isolates of Escherichia coli from Korea. J Med Microbiol 2009;58(Pt 2):261-266. https://doi.org/10.1099/jmm.0.004507-0
- Kang CI, Kim SH, Kim DM, et al. Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2004;25:860-867. https://doi.org/10.1086/502310
- Kim YK, Pai H, Lee HJ, et al. Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother 2002;46:1481-1491. https://doi.org/10.1128/AAC.46.5.1481-1491.2002
- Menashe G, Borer A, Yagupsky P, et al. Clinical significance and impact on mortality of extended-spectrum beta lactamase-producing Enterobacteriaceae isolates in nosocomial bacteremia. Scand J Infect Dis 2001;33:188-193. https://doi.org/10.1080/00365540151060806
- Schwaber MJ, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y. Clinical and economic impact of bacteremia with extended-spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2006;50:1257-1262. https://doi.org/10.1128/AAC.50.4.1257-1262.2006
- Tumbarello M, Spanu T, Sanguinetti M, et al. Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob Agents Chemother 2006;50:498-504. https://doi.org/10.1128/AAC.50.2.498-504.2006
- Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005;18:657-686. https://doi.org/10.1128/CMR.18.4.657-686.2005
-
Kang CI, Park SY, Chung DR, Peck KR, Song JH. Piperacillin- tazobactam as an initial empirical therapy of bacteremia caused by extended-spectrum
${\beta}$ -lactamase-producing Escherichia coli and Klebsiella pneumoniae. J Infect 2012;64:533-534. https://doi.org/10.1016/j.jinf.2012.01.008 -
Rodriguez-Bano J, Navarro MD, Retamar P, Picon E, Pascual A; Extended-Spectrum Beta-Lactamases-Red Espanola de Investigacion en Patología Infecciosa/Grupo de Estudio de Infeccion Hospitalaria Group.
${\beta}$ -Lactam/${\beta}$ -lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum${\beta}$ -lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts. Clin Infect Dis 2012;54:167-174. https://doi.org/10.1093/cid/cir790
피인용 문헌
- Third-generation cephalosporin resistance in gram-negative bacteria in the community: a growing public health concern vol.29, pp.1, 2014, https://doi.org/10.3904/kjim.2014.29.1.27
- Bacteriology and Changes in Antibiotic Susceptibility in Adults with Community-Acquired Perforated Appendicitis vol.9, pp.10, 2014, https://doi.org/10.1371/journal.pone.0111144
- Analysis of the third‐ and fourth‐generation cephalosporin use for the treatment of infections caused by Gram‐negative bacteria in hospital settings vol.70, pp.12, 2014, https://doi.org/10.1111/ijcp.12911
- The Antimicrobial Susceptibility of Klebsiella pneumoniae from Community Settings in Taiwan, a Trend Analysis vol.6, pp.None, 2016, https://doi.org/10.1038/srep36280
- Microbiology and Antimicrobial Therapy for Diabetic Foot Infections vol.50, pp.1, 2014, https://doi.org/10.3947/ic.2018.50.1.11
- Carbapenem susceptibilities of Gram-negative pathogens in intra-abdominal and urinary tract infections: updated report of SMART 2015 in China vol.18, pp.None, 2014, https://doi.org/10.1186/s12879-018-3405-1
- Antimicrobial resistance surveillance among gram-negative bacterial isolates from patients in hospitals in Khartoum State, Sudan vol.8, pp.None, 2019, https://doi.org/10.12688/f1000research.17744.1
- Prevalence of and risk factor for community-onset third-generation cephalosporin-resistant Escherichia coli bacteremia at a medical center in Taiwan vol.19, pp.None, 2014, https://doi.org/10.1186/s12879-019-3880-z
- Aeromonas spp. Isolated from Pacific Abalone (Haliotis discus hannai) Marketed in Korea: Antimicrobial and Heavy-Metal Resistance Properties vol.77, pp.8, 2014, https://doi.org/10.1007/s00284-020-01982-9
- Clinical and Economic Impact of Third-Generation Cephalosporin-Resistant Infection or Colonization Caused by Escherichia coli and Klebsiella pneumoniae : A Multicenter Study in China vol.17, pp.24, 2014, https://doi.org/10.3390/ijerph17249285
- Comparison of antimicrobial resistances and clinical features in community-onset Escherichia coli and Klebsiella pneumoniae bacteremia vol.36, pp.2, 2014, https://doi.org/10.3904/kjim.2019.272